Immune-mediated Neuropathy with Anti-disialosyl IgM Antibodies in Diffuse Large B-cell Lymphoma: A Case Report and Literature Review

  • Shihashi Gen
    Department of Neurology, Keio University School of Medicine, Japan
  • Yagi Takuya
    Department of Neurology, Keio University School of Medicine, Japan
  • Suzuki Shigeaki
    Department of Neurology, Keio University School of Medicine, Japan
  • Seki Morinobu
    Department of Neurology, Keio University School of Medicine, Japan
  • Kohashi Sumiko
    Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan
  • Ueda Tomoki
    Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan
  • Kameyama Kaori
    Department of Pathology, Keio University School of Medicine, Japan
  • Kusunoki Susumu
    Department of Neurology, Kinki University School of Medicine, Japan
  • Nakajima Hideaki
    Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan
  • Okamoto Shinichiro
    Division of Hematology, Department of Medicine, Keio University School of Medicine, Japan
  • Suzuki Norihiro
    Department of Neurology, Keio University School of Medicine, Japan

この論文をさがす

抄録

A 36-year-old man with diffuse large B-cell lymphoma presented with polyneuropathy, and the diagnostic work-up revealed the presence of IgM antibodies against gangliosides with disialosyl residues (GD1b, GD3). He was treated with rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisone and received high-dose intravenous immunoglobulin for the treatment of neuropathy. After initiating the treatments, the patient's neurological impairment improved dramatically. He currently remains in complete remission without a flare-up of the polyneuropathy. Based upon our experience and other case reports of lymphoma with immune-mediated neuropathy caused by anti-disialosyl ganglioside IgM antibodies, we conclude that determining the anti-ganglioside antibody profile and beginning early treatment should be considered promptly for patients with malignant lymphoma who develop polyneuropathy.<br>

収録刊行物

  • Internal Medicine

    Internal Medicine 54 (13), 1647-1651, 2015

    一般社団法人 日本内科学会

被引用文献 (1)*注記

もっと見る

参考文献 (16)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ